Literature DB >> 4026265

Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery.

M G Bergeron, D Desaulniers, C Lessard, M Lemieux, J P Després, J Métras, G Raymond, G Brochu.   

Abstract

The concentrations of cefamandole, cloxacillin and fusicid acid were measured in the serum and heart tissue of 100 recipients of these drugs before cardiac surgery. During cardiopulmonary bypass, mean (+/- standard deviation) peak concentrations in serum of all patients were 63.0 +/- 34.0 micrograms of cefamandole per ml, 30.8 +/- 17.7 micrograms of cloxacillin per ml, and 32.4 +/- 10.8 micrograms of fusidic acid per ml. Mean (+/- standard deviation) concentrations in atrial appendages taken 1 h (+/- 15 min) after infusion were 21.3 +/- 11.0 micrograms of cefamandole per g, 23.8 +/- 17.3 micrograms of cloxacillin per g, and 10.7 +/- 4.2 micrograms of fusidic acid per g. No cloxacillin could be detected in 5 of 39 heart specimens. Mean tissue-to-serum ratios at 1 h for cefamandole, cloxacillin, and fusidic acid were respectively 0.35, 0.73, and 0.33. Fusidic acid, a drug which is highly effective in vitro against both methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis, was detectable in heart tissue in concentrations which were 12 times higher than the MICs of this agent against these resistant microorganisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026265      PMCID: PMC180189          DOI: 10.1128/AAC.27.6.928

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Fucidin: a new orally active antibiotic.

Authors:  W GODTFREDSEN; K ROHOLT; L TYBRING
Journal:  Lancet       Date:  1962-05-05       Impact factor: 79.321

2.  Prophylactic antibiotic therapy and heart valve replacement.

Authors:  T W Austin; J C Coles; R Finley; B Schieven
Journal:  Can J Surg       Date:  1976-07       Impact factor: 2.089

3.  Bactericidal activity and pharmacology of flucloxacillin.

Authors:  M G Bergeron; J L Brusch; M Barza; L Weinstein
Journal:  Am J Med Sci       Date:  1976 Jan-Feb       Impact factor: 2.378

4.  Antibiotic therapy of chronic post-traumatic osteomyelitis.

Authors:  G Hierholzer; J Rehn; H Knothe; J Masterson
Journal:  J Bone Joint Surg Br       Date:  1974-11

5.  Antibiotic resistance of Staphylococcus albus.

Authors:  G Pulverer; G Damen; M Neugebauer
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

6.  A method for studying antibiotic concentrations in inflammatory exudate.

Authors:  J A Raeburn
Journal:  J Clin Pathol       Date:  1971-10       Impact factor: 3.411

7.  The disposition of sodium fusidate in man.

Authors:  R Wise; M Pippard; M Mitchard
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

8.  Comparison of cephalothin and cefamandole prophylaxis during insertion of prosthetic heart valves.

Authors:  G L Archer; R E Polk; R J Duma; R Lower
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

9.  Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices.

Authors:  G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

10.  Cefamandole kinetics during cardiopulmonary bypass.

Authors:  R E Polk; G L Archer; R Lower
Journal:  Clin Pharmacol Ther       Date:  1978-04       Impact factor: 6.875

View more
  5 in total

1.  Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis.

Authors:  L M Baddour; M M Hill; A M Felty-Duckworth
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

2.  Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery.

Authors:  M G Bergeron; R Saginur; D Desaulniers; S Trottier; W Goldstein; P Foucault; C Lessard
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

3.  In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.

Authors:  H Torres; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

4.  Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.

Authors:  J D Peter; F Jehl; T Pottecher; J P Dupeyron; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

5.  Antibiotic activity in serum following single and repeated oral administration of sodium fusidate in volunteers.

Authors:  P Munkholm; H Hey; S N Rasmussen; P B Johansen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Oct-Dec       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.